| abstract |
A non-toxic water-soluble pharmaceutically acceptable derivative of peroxydiphosphoric acid, when administered orally or systemically, inhibits parathyroid hormone induced bone resorption in vitro and in vivo in warm blooded animals. Preferred compounds are alkali metal, zinc, tin or quaternary ammonium salts or C1-12 alkyl, adenylyl, guanylyl, cytosylyl or thymylyl esters. The compound can be used to treat hypocalcaemia. |